Company DocMorris AG

ROSE

CH0042615283

Drug Retailers

Market Closed - Swiss Exchange Other stock markets 11:31:47 2025-07-11 am EDT			5-day change	1st Jan Change
7.005 ^CHF	-2.51%		+5.26%	-64.94%

Jul. 11	DOCMORRIS : Receives a Buy rating from Jefferies	ZD
Jul. 03	DOCMORRIS : Deutsche Bank reaffirms its Neutral rating	ZD

Business description: DocMorris AG

Zur Rose Group AG is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. The Company's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and healthcare companies, among others. The DocMorris division manages the mail-order business for drug retail. The Company operates in Switzerland, Germany and the Netherlands through a number of subsidiaries, such as Zur Rose Suisse AG, Zur Rose Pharma GmbH, BlueCare AG, DocMorris NV, Eurapon Pharmahandel GmbH and Vitalsana BV.

Number of employees: 1,454

Sales by Activity: DocMorris AG

Fiscal Period: December	2020	2021	2022	2023	2024
Germany	821M	1.02B	859M	907M	954M
Europe	66.41M	81.94M	70.45M	62.08M	63.1M
Eliminations	-3.81M	-6.99M	-7.52M	-	-
Switzerland	593M	627M	687M	-	-

See all business segments

Geographical breakdown of sales: DocMorris AG

Fiscal Period: December	2020	2021	2022	2023	2024
Germany	821M	1.02B	859M	907M	954M
Other	66.41M	81.88M	70.45M	62.08M	63.1M
Switzerland	589M	620M	679M	-	-

See all geographic segments

Executive Committee: DocMorris AG

Manager	Title	Age	Since
Walter Hess CEO	Chief Executive Officer	60	2022-04-27
Daniel Wüest DFI	Director of Finance/CFO	55	2024-09-30
Kaspar Niklaus COO	Chief Operating Officer	57	2022-10-31
Daniel Grigat IRC	Investor Relations Contact	-	2022-07-31
David Maso Mas PRN	Corporate Officer/Principal	54	-

See DOCMORRIS AG governance

Composition of the Board of Directors: DocMorris AG

Director	Title	Age	Since
Walter Oberhänsli CHM	Chairman	67	2022-04-27
Stefan Feuerstein CHM	Chairman	70	2010-03-31
Christian Mielsch BRD	Director/Board Member	62	2019-05-22
Florian Seubert BRD	Director/Board Member	52	2019-05-22
Andréa Belliger BRD	Director/Board Member	55	2020-12-31
Rong Rong Hu BRD	Director/Board Member	45	2021-12-31

Composition of the Board of Directors

Shareholders: DocMorris AG

Name	Equities	%	Valuation
Jacek Szwajcowski 10.12 %	5,161,061	10.12 %	41 M CHF
DOCMORRIS AG 5.917 %	3,018,581	5.917 %	24 M CHF
UBS Asset Management Switzerland AG 2.99 %	1,525,435	2.99 %	12 M CHF
Astaris Capital Management LLP 2.99 %	1,525,435	2.99 %	12 M CHF
FundSight SA 1.766 %	900,811	1.766 %	7 M CHF

List of DOCMORRIS AG shareholders

Holdings: DocMorris AG

Name	Equities	%	Valuation
DOCMORRIS AG 5.92%	3,018,581	5.92%	24,175,181 $

Company details: DocMorris AG

DocMorris Ltd.

Walzmuehlestrasse 60

8500, Frauenfeld

http://corporate.docmorris.com

Group companies: DocMorris AG

Name	Category and Sector
Zur Rose Finance BV	Finance/Rental/Leasing

See all subsidiaries

Other Drug Retailers

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
DOCMORRIS AG	-2.51%	+5.26%	-85.48%	-90.25%	422M
JD HEALTH INTERNATIONAL INC.	-0.23%	+2.65%	+99.07%	-31.07%	17.37B
WALGREENS BOOTS ALLIANCE, INC.	-0.35%	+0.44%	+0.79%	-69.22%	9.97B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	+2.34%	+3.55%	+37.42%	-17.70%	8.97B
MATSUKIYOCOCOKARA & CO.	+1.04%	+7.12%	+30.55%	+78.91%	8.41B
CLICKS GROUP LIMITED	-1.59%	-3.72%	+4.66%	+25.99%	4.73B
NAHDI MEDICAL COMPANY	-0.62%	-1.30%	-3.30%	-20.88%	4.46B
YIFENG PHARMACY CHAIN CO., LTD.	-1.41%	-2.12%	+4.62%	-23.41%	4.14B
WELCIA HOLDINGS CO., LTD.	+0.78%	+2.51%	+35.35%	-13.25%	3.65B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	0.00%	+3.64%	-40.19%	+80.95%	2.92B
Average	-0.26%	+1.00%	+8.35%	-7.99%	6.51B
Weighted average by Cap.	+0.12%	+0.79%	+35.71%	-9.87%